Abstract
Objective To evaluate the potential clinical value of quantitative functional FDG PET and pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical assessments in the prediction of Alzheimer's disease (AD) progression.
Original language | English (US) |
---|---|
Article number | e0154406 |
Journal | PLoS One |
Volume | 11 |
Issue number | 5 |
DOIs | |
State | Published - May 1 2016 |
ASJC Scopus subject areas
- Agricultural and Biological Sciences(all)
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)